These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3265226)

  • 1. Von Willebrand factor and mitral valve prolapse.
    Froom P; Margulis T; Grenadier E; Palant A; David M; Aghai E
    Thromb Haemost; 1988 Oct; 60(2):230-1. PubMed ID: 3265226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between von Willebrand factor (VWF) and VWF antigen II in normal individuals and patients with von Willebrand disease.
    de Romeuf C; Mazurier C
    Thromb Haemost; 1998 Jul; 80(1):37-41. PubMed ID: 9684782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
    Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
    Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in von Willebrand factor antigen in premature infants with respiratory distress syndrome and chronic lung disease.
    Patrick CH; Lazarchick J; Horn BS
    Ann Clin Lab Sci; 1993; 23(1):39-46. PubMed ID: 8430999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of calcium channel blockers on the endothelial release of von Willebrand factor after exercise in healthy subjects.
    Musumeci V; Cardillo C; Baroni S; Zuppi C; Zappacosta B; Tutinelli F; Folli G
    J Lab Clin Med; 1989 Apr; 113(4):525-31. PubMed ID: 2784824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Von Willebrand factor antigen levels in Behçet disease.
    Beyan E; Sadikoğlu B; Ertuğrul E; Beyan C
    Am J Hematol; 2005 May; 79(1):70-2. PubMed ID: 15849757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study.
    Favaloro EJ; Lloyd J; Rowell J; Baker R; Rickard K; Kershaw G; Street A; Scarff K; Barrese G; Maher D; McLachlan AJ
    Thromb Haemost; 2007 Jun; 97(6):922-30. PubMed ID: 17549293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2.
    van Vliet HH; Kappers-Klunne MC; Leebeek FW; Michiels JJ
    Thromb Haemost; 2008 Sep; 100(3):462-8. PubMed ID: 18766263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New treatments of von Willebrand disease: plasma derived von Willebrand factor concentrates.
    Menache D; Aronson DL
    Thromb Haemost; 1997 Jul; 78(1):566-70. PubMed ID: 9198217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is visceral adipose tissue a determinant of von Willebrand factor in overweight and obese premenopausal women?
    Mertens I; Van der Planken M; Corthouts B; Van Gaal LF
    Metabolism; 2006 May; 55(5):650-5. PubMed ID: 16631442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of evaluating conventional inflammatory markers in Von Willebrand factor measurement.
    Lippi G; Franchini M; Targher G; Poli G; Guidi GC
    Clin Chim Acta; 2007 Jun; 381(2):167-70. PubMed ID: 17433810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification and characterization of hereditary types 2A, 2B, 2C, 2D, 2E, 2M, 2N, and 2U (unclassifiable) von Willebrand disease.
    Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
    Clin Appl Thromb Hemost; 2006 Oct; 12(4):397-420. PubMed ID: 17000885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. von Willebrand factor antigen in hypertrophic osteoarthropathy.
    Matucci-Cerinic M; Martinez-Lavin M; Rojo F; Fonseca C; Kahaleh BM
    J Rheumatol; 1992 May; 19(5):765-7. PubMed ID: 1613707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers.
    Casonato A; Pontara E; Dannhäuser D; Bertomoro A; Sartori MT; Girolami A
    Haematologia (Budap); 1994; 26(2):97-109. PubMed ID: 7890268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte activation markers and von Willebrand factor antigen in Wegener's granulomatosis: potential markers for disease activity.
    D'Cruz D; Direskeneli H; Khamashta M; Hughes GR
    J Rheumatol; 1999 Jan; 26(1):103-9. PubMed ID: 9918249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitral valve prolapse in myotonic dystrophy.
    Streib EW; Meyers DG; Sun SF
    Muscle Nerve; 1985 Oct; 8(8):650-3. PubMed ID: 4058472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Reliable von Willebrand factor: ristocetin cofactor enzyme-linked immunosorbent assay to differentiate between type 1 and type 2 von Willebrand disease.
    Vanhoorelbeke K; Cauwenberghs N; Vandecasteele G; Vauterin S; Deckmyn H
    Semin Thromb Hemost; 2002 Apr; 28(2):161-6. PubMed ID: 11992239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial clustering of factor VIII and von Willebrand factor levels.
    Kamphuisen PW; Houwing-Duistermaat JJ; van Houwelingen HC; Eikenboom JC; Bertina RM; Rosendaal FR
    Thromb Haemost; 1998 Feb; 79(2):323-7. PubMed ID: 9493584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of von Willebrand factor and its propeptide in plasma in acquired von Willebrand syndrome.
    van Genderen PJ; Boertjes RC; van Mourik JA
    Thromb Haemost; 1998 Sep; 80(3):495-8. PubMed ID: 9759633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.